National Center for Advancing Translational Sciences; Notice of Workshop, 57458 [2019-23280]
Download as PDF
<![CDATA[
57458
Federal Register / Vol. 84, No. 207 / Friday, October 25, 2019 / Notices
interns for the continuing NIDA
Summer Research Internship Program.
This request is to allow NIDA to collect
information from applicants in order to
meet the goals of the program and IC
mission. Applicant eligibility for this
program was 17 years, but is now open
to those 18 and over in the year of
application per NIH policy document
2019 High School Summer Internship
Program (HS–SIP) Policy. NIDA will
which applicants will be selected for
internships. In each case, completing
the application is voluntary, but in
order to receive due consideration, the
prospective applicant must complete all
fields required by the program.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
250.
request clearance for any additional
forms should new programs be
introduced in the future. The
information ensures that students
applying to this program meet basic
eligibility requirements; indicates their
interest in substance abuse research,
future career goals, and, if selected for
the program, what research they prefer
to conduct. The information also
enables decision-making regarding
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Estimated
total annual
burden hours
Form
Type of respondent
Summer Internship ............................
Individuals-household .......................
250
1
1
250
Total ...........................................
...........................................................
........................
250
........................
250
Dated: October 16, 2019.
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2019–23283 Filed 10–24–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Workshop
Notice is hereby given of a workshop
convened by the National Center for
Advancing Translational Sciences Cures
Acceleration Network Review Board.
Purpose
The National Center for Advancing
Translational Sciences is hosting the
Cures Acceleration Network Review
Board (CAN RB) Workshop: The CAN
RB advises and provides
recommendations to the NCATS
Director with respect to significant
barriers to successful translation of basic
science into clinical application. In
support of this mandate, the CAN RB
will co-host this public workshop to
discuss challenges around finding new
uses for drugs that are already on the
market but lack commercial and
regulatory incentives for research and
development.
The Workshop is being co-sponsored
by the NCATS Cures Acceleration
Network Review Board, NCATS Drug
Development Partnership Programs,
Food and Drug Administration, and
Reagan-Udall Foundation for the FDA.
VerDate Sep<11>2014
18:04 Oct 24, 2019
Jkt 250001
Name of Committee: National Center
for Advancing Translational Sciences
Cures Acceleration Network Review
Board.
Type of Meeting: Repurposing OffPatent Drugs: Research & Regulatory
Challenges.
Date: December 5–6, 2019.
Time: 7:30 a.m. to 5:00 p.m., Eastern
Standard Time (EST).
Agenda: The Workshop will assess
challenges around finding new uses for
drugs that are already on the market but
lack commercial and regulatory
incentives for research and
development. On December 5, we will
map out the challenges to repurposing
off-patent drugs. On December 6, we
will host interactive work sessions
focused on capturing possible solutions.
Place: Hilton Washington DC/
Rockville Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville,
MD 20852.
Cost: The meeting is free and open to
the public.
Registration: Registration is required.
Using the link below, attendees can
register by December 2, 2019, 5:00 p.m.
EST. Early registration is recommended
due to limited seating. https://
reaganudall.salsalabs.org/
repurposingoffpatentdrugsworkshop/
index.html.
Access: Twinbrook Metro Station
(Red Line).
Contact Person: Bobbie Ann Mount,
Ph.D., Program Officer, Drug
Development Partnership Programs,
Office of the Director, National Center
for Advancing Translational Sciences,
National Institutes of Health.
Telephone: 301.435.0824, Email:
NewTherapeuticUses@mail.nih.gov.
Disability Accommodations:
Individuals whose full participation in
PO 00000
Frm 00077
Fmt 4703
Sfmt 9990
the workshop will require special
accommodations (e.g., sign language, or
interpreting services, etc.) must submit
a request to the Contact Person listed on
the notice at least ten (10) business days
prior to the meeting. Such requests
should include a detailed description of
the accommodation needed and a way
to contact the requester if more
information is needed to fill the request.
Special requests should be made as
early as possible. Last minute requests
may be made but may not be possible
to accommodate.
Security: Visitors will be asked to
show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state
the purpose of their visit. Also, as a part
of security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
on a first come, first serve basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
For more information, visit: https://
reaganudall.salsalabs.org/
repurposingoffpatentdrugsworkshop/
index.html.
Dated: October 21, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–23280 Filed 10–24–19; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Page 57458]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23280]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Workshop
Notice is hereby given of a workshop convened by the National
Center for Advancing Translational Sciences Cures Acceleration Network
Review Board.
Purpose
The National Center for Advancing Translational Sciences is hosting
the Cures Acceleration Network Review Board (CAN RB) Workshop: The CAN
RB advises and provides recommendations to the NCATS Director with
respect to significant barriers to successful translation of basic
science into clinical application. In support of this mandate, the CAN
RB will co-host this public workshop to discuss challenges around
finding new uses for drugs that are already on the market but lack
commercial and regulatory incentives for research and development.
The Workshop is being co-sponsored by the NCATS Cures Acceleration
Network Review Board, NCATS Drug Development Partnership Programs, Food
and Drug Administration, and Reagan-Udall Foundation for the FDA.
Name of Committee: National Center for Advancing Translational
Sciences Cures Acceleration Network Review Board.
Type of Meeting: Repurposing Off-Patent Drugs: Research &
Regulatory Challenges.
Date: December 5-6, 2019.
Time: 7:30 a.m. to 5:00 p.m., Eastern Standard Time (EST).
Agenda: The Workshop will assess challenges around finding new uses
for drugs that are already on the market but lack commercial and
regulatory incentives for research and development. On December 5, we
will map out the challenges to repurposing off-patent drugs. On
December 6, we will host interactive work sessions focused on capturing
possible solutions.
Place: Hilton Washington DC/Rockville Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Cost: The meeting is free and open to the public.
Registration: Registration is required. Using the link below,
attendees can register by December 2, 2019, 5:00 p.m. EST. Early
registration is recommended due to limited seating. https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/.
Access: Twinbrook Metro Station (Red Line).
Contact Person: Bobbie Ann Mount, Ph.D., Program Officer, Drug
Development Partnership Programs, Office of the Director, National
Center for Advancing Translational Sciences, National Institutes of
Health. Telephone: 301.435.0824, Email:
[email protected].
Disability Accommodations: Individuals whose full participation in
the workshop will require special accommodations (e.g., sign language,
or interpreting services, etc.) must submit a request to the Contact
Person listed on the notice at least ten (10) business days prior to
the meeting. Such requests should include a detailed description of the
accommodation needed and a way to contact the requester if more
information is needed to fill the request. Special requests should be
made as early as possible. Last minute requests may be made but may not
be possible to accommodate.
Security: Visitors will be asked to show one form of identification
(for example, a government-issued photo ID, driver's license, or
passport) and to state the purpose of their visit. Also, as a part of
security procedures, attendees should be prepared to present a photo ID
at the meeting registration desk during the check-in process. Pre-
registration is recommended. Seating will be limited to the room
capacity and seats will be on a first come, first serve basis, with
expedited check-in for those who are pre-registered.
Meeting schedule subject to change.
For more information, visit: https://reaganudall.salsalabs.org/repurposingoffpatentdrugsworkshop/.
Dated: October 21, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-23280 Filed 10-24-19; 8:45 am]
BILLING CODE 4140-01-P
